tirzepatide niacinamide dosing chart tirzepatide/niacinamide Zepbound® Dosage Guide TZ/Niacinamide Injection Service Fee EMPOWER

Your health is our prioritytrust us to be there in your time of need

Approved in November 2023, Zepbound represents a novel therapeutic approach combining dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

In participants with type 2 diabetes, treatment resulted in HbA1c reductions up to 2.2% at 36 weeks, with mean reductions of 1.24% across pooled analyses

Regular movement increases metabolism, improves mood, and supports long-term weight goals

While tirzepatide does not directly cause specific micronutrient deficiencies through its mechanism of action, the secondary effects on eating patterns and gastrointestinal function warrant attention to nutritional adequacy

In a study by Yanai et al., a low dose of pioglitazone that is 7.5 mg/day, was found to show the same improvements in insulin sensitivity as the standard dose (15 mg/day), and high dose (30 mg/day)